The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients
被引:25
作者:
Winston, A
论文数: 0引用数: 0
h-index: 0
机构:
Chelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, EnglandChelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, England
Winston, A
[1
]
Mandalia, S
论文数: 0引用数: 0
h-index: 0
机构:
Chelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, EnglandChelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, England
Mandalia, S
[1
]
Pillay, D
论文数: 0引用数: 0
h-index: 0
机构:
Chelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, EnglandChelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, England
Pillay, D
[1
]
Gazzard, B
论文数: 0引用数: 0
h-index: 0
机构:
Chelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, EnglandChelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, England
Gazzard, B
[1
]
Pozniak, A
论文数: 0引用数: 0
h-index: 0
机构:
Chelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, EnglandChelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, England
Pozniak, A
[1
]
机构:
[1] Chelsea & Westminster Hosp, Dept Genitourinary HIV Med, London SW10 9NH, England
The K65R mutation in HIV-1 reverse transcriptase is associated with reduced susceptibility to abacavir and tenofovir. We established its prevalence within a large clinical database, and investigated correlations with other resistance-associated mutations and antiretroviral history. The presence of K65R is associated with previous abacavir use. Although rare, it is preferentially selected within non-thymidine analogue-containing regimens, compared with concurrent zidovudine or stavudine use, which is associated with thymidine analogue mutations. Both genetic routes may compromise abacavir and tenofovir activity.